Josh Bilenker’s Treeline Biosciences gets another $200M, bringing funding to $1.1Bnews2025-09-03T13:33:30+00:00September 3rd, 2025|Endpoints News|
How past Endpoints 11 winners fared during 2025’s biotech downturnnews2025-09-03T11:00:44+00:00September 3rd, 2025|Endpoints News|
Post-Hoc Live: How we chose this year’s best biotech startups, and how past picks have farednews2025-09-03T11:00:11+00:00September 3rd, 2025|Endpoints News|
Post-Hoc Live: What it takes to build a new biotech in 2025news2025-09-02T13:58:51+00:00September 2nd, 2025|Endpoints News|
Exclusive: Neon Health raises $6M for AI to help patients access specialty drugsnews2025-09-02T13:00:49+00:00September 2nd, 2025|Endpoints News|
John Maraganore, Clive Meanwell team up again with $50M to prevent cardiovascular diseasenews2025-09-02T10:30:45+00:00September 2nd, 2025|Endpoints News|
Nvidia-backed Charm Therapeutics gets $80M to take AI-designed cancer drug to clinicnews2025-09-02T06:00:07+00:00September 2nd, 2025|Endpoints News|
Patient Square raises $3.1B in interim close, as health investor seeks more for second fundnews2025-08-29T14:57:31+00:00August 29th, 2025|Endpoints News|
AbbVie’s Gilgamesh deal highlights pharma’s one-asset mindnews2025-08-29T10:53:43+00:00August 29th, 2025|Endpoints News|
Stanford spinout Shenandoah Therapeutics raises $21.5M to turn cancer drivers against themselvesnews2025-08-28T14:00:36+00:00August 28th, 2025|Endpoints News|
